LUMAKRAS (sotorasib), FDA Approved for Treatment of KRAS G12C-mutated Locally Advanced or Metastatic Non-small Cell Lung Cancer, Available at Biologics by McKesson
CARY, N.C., June 11, 2021 — Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, has been selected by Amgen Oncology as a specialty pharmacy provider for LUMAKRASTM (sotorasib) for the treatment of patients with KRAS G12C-mutated locally advanced ... (Source: McKesson News)
Source: McKesson News - June 11, 2021 Category: Information Technology Source Type: news
First Phase Results of MYLUNG Consortium Provide Historical View of Biomarker Testing Patterns and Identify Data Gaps for Ongoing Prospective Research
Over 80 percent of non-small cell lung cancer detected at Stage 4Fewer than 50 percent of patients had five or more biomarker testsMedian time from diagnosis to first-line therapy is about five weeks (Source: McKesson News)
Source: McKesson News - June 4, 2021 Category: Information Technology Source Type: news
US Oncology Research, The US Oncology Network and Ontada Announce Clinical Data Showcased in Plenary and Oral Sessions at ASCO Annual Meeting
THE WOODLANDS, Texas, June 3, 2021 — US Oncology Research, The US Oncology Network (The Network), and OntadaTM announce they contributed to more than 75 studies covering topics including gynecologic cancer, lung cancer and immunotherapy which will be presented at the upcoming 2021 American Society o... (Source: McKesson News)
Source: McKesson News - June 3, 2021 Category: Information Technology Source Type: news
Community Pharmacies with Health Mart, Health Mart Atlas Administer 1 Million COVID-19 Vaccine Doses
IRVING, Texas, May 19, 2021 —As of today, 1,370 community pharmacies affiliated with Health Mart® and Health Mart Atlas™ have collectively administered one million COVID-19 vaccine doses1. For underserved and rural communities, vaccine access can be a significant challenge in the initiative to reach ... (Source: McKesson News)
Source: McKesson News - May 19, 2021 Category: Information Technology Source Type: news
McKesson Reports Fiscal 2021 Fourth-Quarter Results and Full-Year Results
Fourth-Quarter and Full-Year Highlights: (Source: McKesson News)
Source: McKesson News - May 6, 2021 Category: Information Technology Source Type: news
McKesson Commits to Set Science-Based Targets to Reduce Greenhouse Gas Emissions
IRVING, Texas, May 5, 2021 — McKesson Corporation, a global leader in healthcare, has signed a commitment letter to the Science Based Targets initiative (SBTi), joining over 1,300 companies to commit to setting ambitious targets to reduce greenhouse gas emissions. (Source: McKesson News)
Source: McKesson News - May 5, 2021 Category: Information Technology Source Type: news
McKesson Declares Quarterly Dividend
IRVING, Texas, April 29, 2021 -- The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 42 cents per share of common stock. The dividend will be payable on July 1, 2021, to stockholders of record on June 1, 2021. (Source: McKesson News)
Source: McKesson News - April 29, 2021 Category: Information Technology Source Type: news
McKesson Announces N. Anthony Coles, M.D. Will Not Stand for Re-Election to McKesson Board of Directors
IRVING, Texas, April 19, 2021 — McKesson Corporation today announced that N. Anthony Coles, M.D., informed the company he will not stand for re-election to the McKesson Board of Directors at its next annual shareholders meeting in July 2021. (Source: McKesson News)
Source: McKesson News - April 19, 2021 Category: Information Technology Source Type: news
NULIBRY (fosdenopterin), First and Only FDA-Approved Therapy to Reduce the Risk of Mortality in Patients with Molybdenum Cofactor Deficiency Type A, Available Exclusively at Biologics by McKesson
CARY, N.C., April 19, 2021 —Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, was selected by Origin Biosciences, Inc., an affiliate of BridgeBio Pharma, Inc. (BridgeBio), as the exclusive specialty pharmacy provider for NULIBRYTM (fosdenopterin... (Source: McKesson News)
Source: McKesson News - April 19, 2021 Category: Information Technology Source Type: news
The US Oncology Network continues its rapid growth and enhances surgical expertise with addition of physicians from Texas Colon & amp; Rectal Specialists as a part of Texas Oncology
THE WOODLANDS, Texas, April 1, 2021 —The US Oncology Network (The Network), the largest organization of its kind dedicated to advancing local cancer care and better patient outcomes, continues to expand its reach into local communities while broadening its surgical expertise with the addition of phys... (Source: McKesson News)
Source: McKesson News - April 1, 2021 Category: Information Technology Source Type: news
McKesson Corporation to Announce Fourth Quarter Fiscal 2021 Results on May 6, 2021
IRVING, Texas, April 1, 2021 -- McKesson Corporation (NYSE: MCK) will release its fourth quarter fiscal 2021 financial results after market close on Thursday, May 6, 2021. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financi... (Source: McKesson News)
Source: McKesson News - April 1, 2021 Category: Information Technology Source Type: news
McKesson Approved as QCDR for 2021 MIPS Program Year
IRVING, Texas, March 25, 2021 — For the fifth consecutive year, McKesson has received approval from The Centers for Medicare& Medicaid Services (CMS) to participate in the Merit-based Incentive Payment System (MIPS) as a Qualified Clinical Data Registry (QCDR). As a CMS-approved QCDR, Practice Insi... (Source: McKesson News)
Source: McKesson News - March 25, 2021 Category: Information Technology Source Type: news
Ontada Appoints Susan Shiff, Ph.D., MBA, as President
LAS COLINAS, TEXAS, Mar. 22, 2021 —OntadaTM, McKesson’s oncology technology and insights business, announced today that respected real-world data expert Susan Shiff has joined as President. In this role, Shiff will continue to build on Ontada’s momentum in delivering real-world insights to transform ... (Source: McKesson News)
Source: McKesson News - March 22, 2021 Category: Information Technology Source Type: news
McKesson launches ScriptPAS, empowering oncology practices to reduce time to therapy while enhancing patient care
IRVING, Texas, March 18, 2021 — McKesson, a global leader in healthcare dedicated to supporting the full continuum of care, announced the launch of ScriptPAS™, a pharmacy management solution for oncology practices powered by Biologics by McKesson specialty pharmacy. ScriptPAS is a fee-for-service of... (Source: McKesson News)
Source: McKesson News - March 18, 2021 Category: Information Technology Source Type: news
McKesson Expands Integrated Pharmacy Services for Specialty Clinics
IRVING, Texas, March 16, 2021 — McKesson Corporation, a global healthcare company, announces a new collaboration with Vanderbilt Health Rx Solutions (VHRxS), a national leader in specialty pharmacy strategy and implementation, to offer VHRxS’s full suite of specialty pharmacy consulting services to ... (Source: McKesson News)
Source: McKesson News - March 16, 2021 Category: Information Technology Source Type: news
